| Literature DB >> 23844078 |
Zhijian Wang1, Yongcheng Dong, Nicolas Desneux, Changying Niu.
Abstract
RNA interference (RNAi) has considerable promise for developing novel pest control techniques, especially because of the threat of the development of resistance against current strategies. For this purpose, the key is to select pest control genes with the greatest potential for developing effective pest control treatments. The present study demonstrated that the 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase; HMGR) gene is a potential target for insect control using RNAi. HMGR is a key enzyme in the mevalonate pathway in insects. A complete cDNA encoding full length HMGR (encoding an 837-aa protein) was cloned from Helicoverpa armigera (Lepidoptera: Noctuidae). The HaHMGR (H. armigera HMGR) knockdown using systemic RNAi in vivo inhibited the fecundity of the females, effectively inhibited ovipostion, and significantly reduced vitellogenin (Vg) mRNA levels. Moreover, the oviposition rate of the female moths was reduced by 98% by silencing HaHMGR compared to the control groups. One-pair experiments showed that both the proportions of valid mating and fecundity were zero. Furthermore, the HaHMGR-silenced females failed to lay eggs (approximate 99% decrease in oviposition) in the semi-field cage performance. The present study demonstrated the potential implications for developing novel pest management strategies using HaHMGR RNAi in the control of H. armigera and other insect pests.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23844078 PMCID: PMC3699641 DOI: 10.1371/journal.pone.0067732
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
PCR primers for HaHMGR cDNA cloning from Helicoverpa armigera.
| Primer set | Primer sequence |
| Degenerate primer | (HMGR-F) 5′-ATGAAAGTSTGGGGAGCYCACG-3′ |
| (HMGR-R) | |
| (VG-F) 5′-GGBAACYGAGCSADCAGCAG-3′ | |
| (VG-R) 5′-CCTGYACTGDTGGMCAGCC-3′ | |
| 3′-RACE primer | (HMGR-F3-1) |
| (HMGR-F3-2) | |
| (R3-1) | |
| (R3-2) | |
| (VG-F3-1) | |
| (VG-F3-2)5′- | |
| 5′-RACE primer | (F-5-1)5′-CATGGCTACATGCTGACAGCCTA-3′ |
| (F-5-2) | |
| (HMGR-R5-1) | |
| (HMGR-R5-2) | |
| (VG-R5-1)5′- | |
| (VG-R5-2)5′- | |
| Quantitative PCR | (QActin-F)5′-TCCAGCCCTCATTCTTGGGTAT-3′ |
| (QActin-R)5′- CAAGTCCTTACGGATGTCAACA-3′ | |
| (QHMGR-F)5′- TACAGTAGGTGGAGGGAC-3′ | |
| (QHMGR-R)5′- ATCAAGGAGGCTAATCGGG-3′ | |
| (QVG-F)5′-CGGAGACAAGAAACAGAACAC-3′ | |
| (QVG-R)5′-AAGCAATAATGCGGACGAGAAT-3′ | |
| RNAi | (T7EGFP-F)5′-TAATACGACTCACTATAGGGAGACCCTGAAGTTCATCTGCACC-3′ |
| (T7EGFP-R)5′- TAATACGACTCACTATAGGGAGAGTGCTCAGGTAGTGGTTGTC-3′ | |
| (T7HMGR-F)5′-TAATACGACTCACTATAGGGAGATCCCTATGGCTACAACTGAAGG-3′ | |
| (T7HMGR-R)5′-TAATACGACTCACTATAGGGAGACCAGCCGATTTAAGCAC-3′ |
Figure 1Neighbor-joining phylogenetic tree of the amino acid sequences of HMGR by Molecular Evolutionary Genetics Analysis Software Version 4.0 (MEGA4).
The branches were statistically evaluated by bootstrap analysis. All sequences were from GenBank.
Figure 2The relative expression of Helicoverpa armigera HMGR (HaHMGR) and vitellogenin mRNA in female pupae.
(A) The expression pattern of HaHMGR at different ages (day 1 to day 9). (B) The expression pattern of vitellogenin at different ages (day 1 to day 9). The mean and SD values were obtained using SPSS version 16.0. Values with the same letter are not significantly different at the P>0.05 level (ANOVA followed by Tukey’s post-hoc test).
Figure 3The relative expression of Helicoverpa armigera HMGR (HaHMGR) and vitellogenin in H. armigera after injecting dsRNA.
(A) Histograms represent the expression of HaHMGR after injecting HaHMGR double-stranded RNA (dsHaHMGR). (B) The expression of vitellogenin after injecting dsHaHMGR. The enhanced green fluorescent protein double-stranded RNA (dsEGFP) treatment group was used as a negative control, and nuclease-free water was used as a blank control. Values with the same letter are not significantly different at the P>0.05 level (ANOVA followed by Tukey’s post-hoc test).
Figure 4Effects of Helicoverpa armigera HMGR (HaHMGR) RNA interference (RNAi) on the oviposition of H. armigera.
Twenty dsRNA-treated or nuclease-free water-treated females were mated with untreated males in cages (40 cm×30 cm×30 cm). The enhanced green fluorescent protein double-stranded RNA (dsEGFP) treatment group was used as a negative control. Nuclease-free water was used as a blank control. Histograms represent the average oviposition per female. Values with the same letter are not significantly different at the P>0.05 level (ANOVA followed by Tukey’s post-hoc test).
Effect of dsHaHMGR on fecundity, larval production and number of spermatophores in Helicoverpa armigera.
| blank control | dsEGFP-treated (negative control) | dsHaHMGR-treated | |
| Proportion of valid mating | 53.33% | 46.67% | 0 |
| Fecundity | 1137.63±241.50a | 1113.00±141.29a | 0b |
| Number of larvae emerging | 493.63±212.90a | 422.00±56.79a | 0b |
| Proportion of larvae emerging | 0.43±0.13a | 0.37±0.08a | - |
| Number of spermatophores | 1.71±0.71a | 2.20±0.90a | 0b |
Two-day-old female pupae were treated with 1 µg of HaHMGR double-stranded RNA (dsHaHMGR) or enhanced green fluorescent protein double-stranded RNA (dsEGFP) (negative control). One female treated with dsRNA (dsHaHMGR or dsEGFP) was paired with an untreated male in a small cage (N = 30). Values are expressed in absolute terms as a percentage or as the mean ± SD. Values with the same letter are not significantly different at the P>0.05 level (ANOVA followed by Tukey’s post-hoc test).
Fecundity and number of emerging Helicoverpa armigera larvae in the greenhouse cage trial.
| dsEGFP-treated (negative control) | dsHaHMGR-treated | |
| Fecundity | 901.00±184.01a | 8.67±4.04b |
| Number of larvae emerging | 152.67±39.70a | 0b |
Twenty pairs of moths were released in a screened quarantine cage (2 m×2 m×2 m) located in a greenhouse, which contained four mature cotton plants. The total number of eggs or larvae was recorded. Values are expressed in absolute terms as the mean ± SD. Values with the same letter are not significantly different at the P>0.05 level (ANOVA followed by a t-test).